Immune-enhancing effects of Astragalus polysaccharides and Ganoderma lucidum polysaccharides on Vibrio harveyi flgJ DNA vaccine in grouper

被引:6
|
作者
Lin, Guixiang [1 ,2 ]
Da, Fan [1 ,2 ]
Wan, Xiaoju [1 ,2 ]
Huang, Yucong [1 ,2 ,3 ]
Yang, Shiping [1 ,2 ,3 ]
Jian, Jichang [1 ,2 ,3 ]
Cai, Shuanghu [1 ,2 ,3 ]
机构
[1] Guangdong Ocean Univ, Fisheries Coll, Guangdong Higher Educ Inst, Guangdong Prov Key Lab Aquat Anim Dis Control & H, Zhanjiang, Peoples R China
[2] Guangdong Ocean Univ, Fisheries Coll, Guangdong Higher Educ Inst, Key Lab Control Dis Aquat Econ Anim, Zhanjiang, Peoples R China
[3] Guangdong Ocean Univ, Guangdong Prov Engn Res Ctr Aquat Anim Hlth Asses, Shenzhen Inst, Shenzhen, Peoples R China
基金
中国国家自然科学基金;
关键词
adjuvant; Astragalus polysaccharides; DNA vaccine; Ganoderma lucidum polysaccharides; pearl gentian grouper; GROWTH; PERFORMANCE; FLOUNDER; ADJUVANT; CELLS; CARP; APS;
D O I
10.1111/jfd.13728
中图分类号
S9 [水产、渔业];
学科分类号
0908 ;
摘要
Astragalus polysaccharides (APS) and Ganoderma lucidum polysaccharides (GLP) have been shown to possess strong immunoregulatory properties in aquatic animals. In this study, the fragment containing Vibrio harveyi flgJ gene was ligated into pcDNA3.1(+) vector and pcDNA3.1(+)-flgJ was constructed as DNA vaccine. APS and GLP were used as DNA vaccine adjuvants to evaluate the immunoregulatory effect by intramuscular injection to pearl gentian grouper (female Epinephelus fuscoguttatus x male E. lanceolatus). The results showed that pcDNA3.1(+)-flgJ combined with APS or GLP could significantly up-regulate the innate and adaptive immune response in fish, including serum-specific antibody titres, catalase and lysozyme activities. At the same time, DNA vaccine combined with APS or GLP significantly up-regulated the expression levels of CD8 alpha, IgM, IL-1 beta, MHC-I alpha, MyD88 and TLR3 genes in thymus, head kidney, spleen and liver of pearl gentian grouper in comparison with those of the pFlgJ group. After 42 days post-vaccination, V. harveyi was used to challenge pearl gentian grouper by intraperitoneal injection. The relative percentage of survival (RPS) of pFlgJ, pFlgJ +APS, pFlgJ +GLP and pFlgJ+APS+GLP groups were 69%, 81%, 77% and 88%, respectively. These results suggested APS and GLP were potential adjuvants for DNA vaccine against V. harveyi infection in pearl gentian grouper.
引用
收藏
页码:147 / 156
页数:10
相关论文
共 5 条
  • [1] Effects of dietary Astragalus polysaccharides on growth, health and resistance to Vibrio harveyi of Lates calcarifer
    Yu, Wei
    Yang, Yukai
    Zhou, Qicun
    Huang, Xiaolin
    Huang, Zhong
    Li, Tao
    Wu, Qiaer
    Zhou, Chuanpeng
    Ma, Zhenhua
    Lin, Heizhao
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 207 : 850 - 858
  • [2] Effect of Ganoderma lucidum polysaccharides as immunostimulants against Vibrio harveyi in pearl gentian grouper (♀Epinephelus fuscoguttatus x ♂Epinephelus lanceolatus)
    Zhang, Yilin
    Zhong, Jian
    Huang, Yucong
    Jian, Jichang
    Cai, Shuanghu
    FRONTIERS IN MARINE SCIENCE, 2022, 9
  • [3] Immune-Enhancing Effects of Taishan Pinus massoniana Pollen Polysaccharides on DNA Vaccine Expressing Bordetella avium ompA
    Zhu, Fujie
    Liu, Xiao
    Sun, Zhenhong
    Yu, Cuilian
    Liu, Liping
    Yang, Shifa
    Li, Bing
    Wei, Kai
    Zhu, Ruiliang
    FRONTIERS IN MICROBIOLOGY, 2016, 7
  • [4] Immune effect of Vibrio harveyi formalin-killed cells vaccine combined with chitosan oligosaccharide and astragalus polysaccharides in ♀Epinephelus fuscoguttatus x ♂Epinephelus lanceolatus
    Wei, Guangben
    Cai, Shuanghu
    Wu, Yuanzhi
    Ma, Shaohong
    Huang, Yucong
    FISH & SHELLFISH IMMUNOLOGY, 2020, 98 : 186 - 192
  • [5] GPP (composition of Ganoderma lucidum polysaccharides and Polyporus umbellatus polysaccharides) protects against DSS-induced murine colitis by enhancing immune function and regulating intestinal flora
    Li, Liyuan
    Guo, Yannan
    Huang, Qing
    Shi, Xiaojin
    Liu, Qingqing
    Wang, Fang
    Liu, Qingfei
    Yu, Kang
    Wang, Zhao
    FOOD SCIENCE AND HUMAN WELLNESS, 2022, 11 (04) : 795 - 805